Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-24-019058
Filing Date
2024-04-29
Accepted
2024-04-29 16:55:37
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2024defa14a.htm DEFA14A 12776
2 ballot2024.jpg GRAPHIC 72742
3 meetinginformation2024.jpg GRAPHIC 117274
  Complete submission text file 0001628280-24-019058.txt   274541
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38295 | Film No.: 24892176
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)